GPP
Great Point Partners’s Travere Therapeutics TVTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-60,000
| Closed | -$922K | – | 48 |
|
|
2023
Q2 | $922K | Sell |
60,000
-943,000
| -94% | -$14.5M | 0.18% | 36 |
|
|
2023
Q1 | $22.6M | Buy |
1,003,000
+528,000
| +111% | +$11.9M | 4.43% | 9 |
|
|
2022
Q4 | $9.99M | Sell |
475,000
-491,108
| -51% | -$10.3M | 1.96% | 20 |
|
|
2022
Q3 | $23.8M | Sell |
966,108
-5,125
| -0.5% | -$126K | 5.73% | 5 |
|
|
2022
Q2 | $23.5M | Sell |
971,233
-38,767
| -4% | -$939K | 5.64% | 4 |
|
|
2022
Q1 | $26M | Buy |
1,010,000
+210,000
| +26% | +$5.41M | 6.29% | 3 |
|
|
2021
Q4 | $24.8M | Buy |
800,000
+175,000
| +28% | +$5.43M | 5.52% | 4 |
|
|
2021
Q3 | $15.2M | Sell |
625,000
-459,300
| -42% | -$11.1M | 3.53% | 10 |
|
|
2021
Q2 | $15.8M | Buy |
1,084,300
+490,588
| +83% | +$7.16M | 3.32% | 10 |
|
|
2021
Q1 | $14.8M | Buy |
+593,712
| New | +$14.8M | 3.06% | 16 |
|
|
2019
Q4 | – | Sell |
-1,740,000
| Closed | -$20.2M | – | 43 |
|
|
2019
Q3 | $20.2M | Buy |
1,740,000
+736,400
| +73% | +$8.54M | 1.85% | 15 |
|
|
2019
Q2 | $20.2M | Buy |
+1,003,600
| New | +$20.2M | 2.24% | 12 |
|